Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Nerve degeneration" patented technology

Application of glutaric acid or pharmaceutical salt thereof in medicine, pharmaceutical composition and pharmaceutical preparation

PendingCN121570448AOrganic active ingredientsNervous disorderNerve degenerationGlutaric acid
The invention discloses application of glutaric acid or medicinal salt thereof in medicine, a medicine composition and a medicine preparation, and belongs to the field of medicine application. According to the application of the glutaric acid or the medicinal salt thereof in preparing the medicine for inhibiting neurodegeneration, promoting lysosomal activity and treating the Alzheimer's disease, a new potential treatment medicine is provided for treatment of the Alzheimer's disease, and a more effective scheme for treating the Alzheimer's disease is provided.
Owner:CAPITAL UNIVERSITY OF MEDICAL SCIENCES

Active substance of Lactobacillus plantarum GKM3, a composition comprising thereof and its use for promoting longevity

ActiveUS12648973B2Powder deliveryNervous disorderBiotechnologyNerve degeneration
The present invention provides an active substance of Lactic Acid Bacteria, a composition comprising thereof and its use for promoting longevity, especially for increasing Cisd2 gene expression, reducing mitochondrial damage and delaying aging conditions such as nerve degeneration and sarcopenia.
Owner:GRAPE KING BIO LTD

Compositions comprising chemerin analogs and methods of use

ActiveUS12559523B2Peptide/protein ingredientsAntipyreticDiseaseNerve degeneration
The present disclosure relates to peptide compositions and methods for treating an inflammatory condition such as ocular inflammation, retinal inflammation, dry eye, uveitis, allergic conjunctivitis, and inflammation resulting from nerve injury or nerve degeneration. The peptide compositions disclosed herein can also be used for treating pain such as neuropathic pain, ocular pain, chronic pain, pain resulting from chemotherapy or radiation, pain resulting from nerve injury or nerve degeneration, and pain resulting from an inflammatory condition, dysesthesia, or allodynia.
Owner:OKYO PHARM LTD